Aakash Tiwari

Akash Tewari is a Managing Director and Global Head of Biopharmaceutical Research at Jefferies, specializing in equity research covering the biotech and pharmaceutical sectors with a focus on SMID Cap Biotech companies. He has demonstrated consistent performance as a recognized top-ranked analyst, maintaining a 38-39% success rate with an average return of 3.2-3.82% per rating across his 455+ stock ratings since 2018, with notable achievements including a +400.60% return on his highest-performing recommendation. Tewari's career spans over a decade in equity research, beginning at Evercore as a Vice President and Biotech Analyst from 2015-2018, followed by a Senior Analyst role at Wolfe Research from 2018-2021, before joining Jefferies in 2021 where he has led biopharmaceutical research coverage. He holds an undergraduate degree from Cornell University and maintains FINRA registration as a regulated broker.